You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (405)

Journals (0)

1-10 of 405 results for HER2-negative breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes

Free access

Research article

First published 2023-03-02

Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes

Romuald Ferre, Janne Elst, Seanthan Senthilnathan [...]

Breast Disease

Select article: Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines

Open access

Research article

First published 2011

Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines

Tuba Ozbay, Rita Nahta

Breast Cancer: Basic and Clinical Research

Select article: CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Open access

Review article

First published 2018

CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Adriana Matutino, Carla Amaro, Sunil Verma

Therapeutic Advances in Medical Oncology

Select article: HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis

Open access

Research article

First published 2024

HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis

Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan [...]

Therapeutic Advances in Medical Oncology

Select article: Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer

Open access

Research article

First published 2025

Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer

Cuiyan Yang, Haoyu Wang, Yiwei Tong [...]

Therapeutic Advances in Medical Oncology

Select article: Comparative Toxicities of Neoadjuvant Chemotherapy With or Without Bevacizumab in HER2-Negative Breast Cancer Patients: A Meta-analysis

Retricted access

Research article

First published 2020-6

Comparative Toxicities of Neoadjuvant Chemotherapy With or Without Bevacizumab in HER2-Negative Breast Cancer Patients: A Meta-analysis

Bi-Cheng Wang, Chen Fu, Lin-Ka Xie [...]

Annals of Pharmacotherapy

Select article: Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Open access

Review article

First published 2025

Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Karam Aboud, Magda Meissner, Rob Jones

Therapeutic Advances in Medical Oncology

Select article: Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Free access

Research article

First published 2021-11-05

Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Jun Yamamura, Yukiko Miyamura, Shunji Kamigaki [...]

Breast Disease

Select article: Comparison of neoadjuvant chemotherapy response and prognosis among pegylated liposomal doxorubicin,epirubicin and pirarubicin in HR ⩽ 10%/HER2-negative breast cancer: an exploratory real-world multicentre cohort study

Open access

Research article

First published 2024

Comparison of neoadjuvant chemotherapy response and prognosis among pegylated liposomal doxorubicin,epirubicin and pirarubicin in HR ⩽ 10%/HER2-negative breast cancer: an exploratory real-world multicentre cohort study

Yue Hong, Jing Peng, Qitong Chen [...]

Therapeutic Advances in Medical Oncology

Select article: Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Open access

Research article

First published 2021

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
41
10 / page

Article type

Publication date

Subjects

Access